Genoil (GNOLF) Capital Expenditures (2009 - 2014)

Genoil (GNOLF) has 6 years of Capital Expenditures data on file, last reported at -$1804.0 in Q1 2014.

• On a quarterly basis, Capital Expenditures rose 8.62% year-over-year to -$1804.0 in Q1 2014; TTM through Mar 2014 was -$1803.1, a 89.55% increase from a year earlier, with the FY2013 full-year figure at -$1930.6, up 94.88% from the prior year.
• Capital Expenditures for Q1 2014 stood at -$1804.0, down from $0.95 in the prior quarter.
• Over the last five years, Capital Expenditures for GNOLF reached as high as $57657.6 in Q3 2012 and fell as low as -$115751.8 in Q4 2011.
• Historically, Capital Expenditures has averaged -$25331.0 across 5 years, with a median of -$13516.4 in 2012.
• Across the five-year window, Capital Expenditures plunged 1250.67% in 2011 and surged 200.26% in 2012, its largest moves.
• Year by year, Capital Expenditures stood at -$4257.6 in 2010, then slumped by 2618.7% to -$115751.8 in 2011, then surged by 36.99% to -$72931.6 in 2012, then surged by 100.0% to $0.95 in 2013, then slumped by 189330.94% to -$1804.0 in 2014.
• Per Business Quant data, the three most recent Capital Expenditures figures were -$1804.0 in Q1 2014, $0.95 in Q4 2013, and -$1974.1 in Q1 2013.